Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It’s funny that you care so much. MAA submission within weeks. :)
Truly crazy how much you post here, given the fact that you claim to have no investment.
I prefer to listen to the real life experts, not anonymous message board posters. I encourage you to read what the real experts say:
https://braintumourresearch.org/en-us/blogs/research-campaigning-news/astonishing-results-for-brain-tumour-vaccine-trial
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
https://www.urmc.rochester.edu/news/story/personalized-immune-therapy-extended-survival-in-patients-with-aggressive-brain-cancer
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
Good stuff. Thanks!
They will submit in 2023. Fact.
Let’s compare your opinion to the opinions of real experts:
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
https://braintumourresearch.org/en-us/blogs/research-campaigning-news/astonishing-results-for-brain-tumour-vaccine-trial
https://www.urmc.rochester.edu/news/story/personalized-immune-therapy-extended-survival-in-patients-with-aggressive-brain-cancer
Update:
Very good news!
https://gofund.me/2e4aa281
Published yesterday:
“The concept that boosting the immune system properly leads to an effective antitumor response in GB has been recently demonstrated by the phase III trial with DCVax-L vaccine which has met both primary and secondary endpoints with extended patient survival for several months.”
https://onlinelibrary.wiley.com/doi/10.1111/imm.13710
As always, when you continue to post here nonstop 24/7 (even on weekends and holidays) we know this is a great investment. Your presence here gives many comfort. It’s really quite interesting, isn’t it. :)
Excellent summary. Thanks
That’s exactly what you said about a peer-reviewed article. Then, bam! See JAMA Oncology article in link below :)
https://braintumourresearch.org/blogs/research-campaigning-news/astonishing-results-for-brain-tumour-vaccine-trial
Wow, you’ve been posting here a lot today, AGAIN. Almost as if it’s your job……
Because Sawston manufacturing development = NWBO manufacturing development despite Exwannabe constantly suggesting otherwise.
You are absolutely correct. We already know about Poorman’s history. Indeed, he was sued in FL for the same type of attempted stock manipulation behavior.
It is true innovation is hard to come by. But disruptive innovation could be an once-in-a-life-time thing.
— d_stock (@d_stock07734) October 5, 2023
You will feel surreal for being a shareholder. Take a look again at the measures in the combo trial. They are purely biomarker driven. This is the sign of revolution. pic.twitter.com/375kuieccN
The success of the Visionary Ball is vital to UCLA Neurosurgery’s mission of delivering high-quality patient care, advancing research, and educating the next generation of leading neurosurgeons and neuroscientists.
— UCLA Neurosurgery 🧠 (@UCLANsgy) October 8, 2023
To learn more, visit our website: https://t.co/XUO2XMikyP pic.twitter.com/3l4pyiO2nh
Sound familiar?
Thanks for the idea! And I thought you were only Here To Drop Garbage. #AskBard "Is Aristides Capital LLC known to pay people to bash stocks on Twitter?" $MMTLP #ReleaseTheBlueSheets pic.twitter.com/nPO8h8MPVW
— Rare DD (@RareDealsHere) June 19, 2023
The fact that you can’t understand DCVAX-L is a breakthrough treatment, according to the experts, is insane.
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
➡️Developing Story Line: A Naked Short Covering Scheme⬅️$NWBO
— hoffmann6383 (@hoffmann6383) October 4, 2023
When following a lawsuit it's interesting to see the different narratives put forth by the Defendant and Plaintiff.
On the Plaintiff's side, $NWBO has a developing narrative that the spoofing is being done to…
“Did not have its own control arm and instead presented external control data” $NWBO pic.twitter.com/p9e8c1m5WF
— Michael Bigger (@biggercapital) October 4, 2023
The Visionary Ball is an event hosted by UCLA Neurosurgery that raises critical funds and awareness in support of neurosurgery patients who face complex neurological disorders.
— UCLA Neurosurgery 🧠 (@UCLANsgy) October 3, 2023
To learn more and purchase tickets, visit our website: https://t.co/XUO2XMikyP#Neurosurgery pic.twitter.com/XnRa9KAuTj
Yes, I remember that too. :)
Good post, Doc. I agree.
Excellent post.
Yup Brown Neurosurgery is a boiler room. Lol
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
Exactly. And he is posting here on a Sunday. Someone is paying him and he is being paid for a reason. Think about it…
Ask your boss if the naked short squeeze will take this north of $50/share. I’ve heard that’s why you’re posting here on a Sunday.
I agree. The court is taking this step, imho, so that the defendants are provided with every opportunity to state their positions. When MTD is denied they will be left with nothing left to argue.
Well said.
I actually see it as a good thing, especially now that NWBO has the fresh order from the other case in hand.
This statement from you: “Could Herrington influence the judge in the Citadel case, it’s possibility, but I doubt it.”
Shows how little you know about the law. While the decision is not binding precedent, it’s absolutely persuasive authority that is highly likely to be followed. That’s why trial attorneys attach prior court orders dealing with the same issue to motions that they have filed. This is done every single day and it’s done for a very good reason. You’re out of your league here, Poorman.
Btw, how’s your personal litigation going? ;)
Lots of FUD in that post, Ex. What a way to spend your Sunday! This is a NWBO PR, not a LP PR. Enjoy the rest of your weekend. ;)
https://nwbio.com/northwest-biotherapeutics-and-advent-bioservices-announce-receipt-of-license-for-commercial-manufacturing-at-sawston-u-k-facility/
Developing commercial manufacturing capability takes time. Don’t worry, DCVAX will be commercially approved later this year. I suggest you read what the experts say in the links below.
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
https://www.braintumourresearch.org/media/news/news-item/2022/11/18/astonishing-results-for-brain-tumour-vaccine-trial